Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 28, 2008American Journal of HematologyOpen Access

Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSpero R. CatalandThe Ohio State University Wexner Medical CenterMJMing JinHeilongjiang University of Chinese MedicineSLShili LinThe Ohio State University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cataland et al. (2008) studied this question.

synapsesocial.com/papers/6ab8c191391c411bd1d8e47ehttps://doi.org/10.1002/ajh.21281
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ciclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long‐term follow‐up with serial analysis of ADAMTS13 activity2007 · 61 citations
  2. 2Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse2008 · 137 citations
  3. 3Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura2005 · 168 citations
  4. 4An evaluation of ciclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura2006 · 76 citations
  5. 5TTP and ADAMTS13: When Is Testing Appropriate?2007 · 65 citations